Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients
NCT ID: NCT05068973
Last Updated: 2023-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
35 participants
INTERVENTIONAL
2021-11-18
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At the time of insertion near the tumor, the Luciola's 3 fiducial marker arms are deployed simultaneously. Optimal detection of the fiducial marker is considered during the radiotherapy treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer
NCT04684186
Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy
NCT04310891
Marker Guided Breathhold Radiotherapy in NSCLC
NCT02447900
CT-controlled Advanced Navigation Techniques for Transbronchial Pulmonary Lesion Access; Evaluation of Augmented Fluoroscopy Bronchoscopic Navigation Based Diagnostic Yield
NCT03274609
Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
NCT02788461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Luciola
Bronchoscopic implantation of the fiducial marker NOVATECH® LUCIOLA™ EB prior to radiotherapy treatment.
NOVATECH® LUCIOLA™ EB - (Fiducial Marker)
Bronchoscopic implantation in the lung of the NOVATECH® LUCIOLA™ EB fiducial marker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NOVATECH® LUCIOLA™ EB - (Fiducial Marker)
Bronchoscopic implantation in the lung of the NOVATECH® LUCIOLA™ EB fiducial marker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with primary, secondary or metastatic lung cancer with an indication for radiotherapy and placement of a fiducial marker
* Participants who will be able to tolerate the flexible bronchoscopic implantation procedure and radiotherapy treatment.
* Participants who give their written informed consent
Exclusion Criteria
* Participants with a bronchoscopy contra-indication
* Pregnant or breast-feeding women
* Participants with known allergy to one of the components (tantalum and nickel titanium alloy for the marker and polymer materials which are contained in the delivery device)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NOVATECH SA
UNKNOWN
Hospital St. Joseph, Marseille, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ESCARGUEL Bruno
Pulmonologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno Escarguel, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Saint Joseph, Marseille France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de radiothérapie Francois Baclesse
Caen, , France
Hopital Saint Joseph
Marseille, , France
Hôpital Privé Clairval-Ramsay Santé
Marseille, , France
CHU Rouen
Rouen, , France
Centre de radiothérapie Henri Becquerel
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jean-Baptiste Paoli, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LUCIOLA 2020_10_02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.